Retinal Disorders Treatment Market, Global Outlook and Forecast 2022-2028

January 2022 | 67 pages | ID: R25B6241CD85EN
Market Monitor Global

Abstracts

Technological advancements are set to play a key role in the overall growth of the global retinal disorders treatment market in the upcoming years. Groundbreaking breakthroughs and advancements in bionics, genetics, and stem-cell therapy are expected to transform the future of retinal disorders treatment in the upcoming decade. In developed regions wherein the preventable causes of blindness are detected early, owing to routine checkups and robust healthcare ecosystem, retinal degeneration has emerged as one of the top causes of blindness or visual impairment. Macular degeneration is of two types: wet age-related macular degeneration and dry age-related macular degeneration. Diabetic retinopathy is one of the common diabetic eye disorders characterized by damaged blood vessels in the retina. The damaged blood vessels and nerves lead to vision impairment, blurring of vision, and eye hemorrhage. If left untreated, it could lead to retinal detachment and blindness.

This report contains market size and forecasts of Retinal Disorders Treatment in Global, including the following market information:

Global Retinal Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Retinal Disorders Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Gels Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Retinal Disorders Treatment include Allergan plc, Bayer AG, F., Hoffmann-La Roche Ltd., Graybug Vision, Inc., Kubota Pharmaceutical Holdings Co., Ltd., Novartis AG, Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Company Limited and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retinal Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Retinal Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Retinal Disorders Treatment Market Segment Percentages, by Type, 2021 (%)

• Gels
• Ointments
• Capsules & Tablets
• Eye Drops

Global Retinal Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Retinal Disorders Treatment Market Segment Percentages, by Application, 2021 (%)

• Macular Degeneration
• Diabetic Retinopathy
• Diabetic Macular Edema
• Others

Global Retinal Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Retinal Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Retinal Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Retinal Disorders Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan plc
• Bayer AG, F.
• Hoffmann-La Roche Ltd.
• Graybug Vision, Inc.
• Kubota Pharmaceutical Holdings Co., Ltd.
• Novartis AG
• Regeneron Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
• Takeda Pharmaceutical Company Limited
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Retinal Disorders Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Retinal Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RETINAL DISORDERS TREATMENT OVERALL MARKET SIZE

2.1 Global Retinal Disorders Treatment Market Size: 2021 VS 2028
2.2 Global Retinal Disorders Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Retinal Disorders Treatment Players in Global Market
3.2 Top Global Retinal Disorders Treatment Companies Ranked by Revenue
3.3 Global Retinal Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Retinal Disorders Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Retinal Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retinal Disorders Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Retinal Disorders Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Retinal Disorders Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Retinal Disorders Treatment Market Size Markets, 2021 & 2028
  4.1.2 Gels
  4.1.3 Ointments
  4.1.4 Capsules & Tablets
  4.1.5 Eye Drops
4.2 By Type - Global Retinal Disorders Treatment Revenue & Forecasts
  4.2.1 By Type - Global Retinal Disorders Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Retinal Disorders Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Retinal Disorders Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Retinal Disorders Treatment Market Size, 2021 & 2028
  5.1.2 Macular Degeneration
  5.1.3 Diabetic Retinopathy
  5.1.4 Diabetic Macular Edema
  5.1.5 Others
5.2 By Application - Global Retinal Disorders Treatment Revenue & Forecasts
  5.2.1 By Application - Global Retinal Disorders Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Retinal Disorders Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Retinal Disorders Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Retinal Disorders Treatment Market Size, 2021 & 2028
6.2 By Region - Global Retinal Disorders Treatment Revenue & Forecasts
  6.2.1 By Region - Global Retinal Disorders Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Retinal Disorders Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Retinal Disorders Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Retinal Disorders Treatment Revenue, 2017-2028
  6.3.2 US Retinal Disorders Treatment Market Size, 2017-2028
  6.3.3 Canada Retinal Disorders Treatment Market Size, 2017-2028
  6.3.4 Mexico Retinal Disorders Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Retinal Disorders Treatment Revenue, 2017-2028
  6.4.2 Germany Retinal Disorders Treatment Market Size, 2017-2028
  6.4.3 France Retinal Disorders Treatment Market Size, 2017-2028
  6.4.4 U.K. Retinal Disorders Treatment Market Size, 2017-2028
  6.4.5 Italy Retinal Disorders Treatment Market Size, 2017-2028
  6.4.6 Russia Retinal Disorders Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Retinal Disorders Treatment Market Size, 2017-2028
  6.4.8 Benelux Retinal Disorders Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Retinal Disorders Treatment Revenue, 2017-2028
  6.5.2 China Retinal Disorders Treatment Market Size, 2017-2028
  6.5.3 Japan Retinal Disorders Treatment Market Size, 2017-2028
  6.5.4 South Korea Retinal Disorders Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Retinal Disorders Treatment Market Size, 2017-2028
  6.5.6 India Retinal Disorders Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Retinal Disorders Treatment Revenue, 2017-2028
  6.6.2 Brazil Retinal Disorders Treatment Market Size, 2017-2028
  6.6.3 Argentina Retinal Disorders Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Retinal Disorders Treatment Revenue, 2017-2028
  6.7.2 Turkey Retinal Disorders Treatment Market Size, 2017-2028
  6.7.3 Israel Retinal Disorders Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Retinal Disorders Treatment Market Size, 2017-2028
  6.7.5 UAE Retinal Disorders Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan plc
  7.1.1 Allergan plc Corporate Summary
  7.1.2 Allergan plc Business Overview
  7.1.3 Allergan plc Retinal Disorders Treatment Major Product Offerings
  7.1.4 Allergan plc Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.1.5 Allergan plc Key News
7.2 Bayer AG, F.
  7.2.1 Bayer AG, F. Corporate Summary
  7.2.2 Bayer AG, F. Business Overview
  7.2.3 Bayer AG, F. Retinal Disorders Treatment Major Product Offerings
  7.2.4 Bayer AG, F. Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bayer AG, F. Key News
7.3 Hoffmann-La Roche Ltd.
  7.3.1 Hoffmann-La Roche Ltd. Corporate Summary
  7.3.2 Hoffmann-La Roche Ltd. Business Overview
  7.3.3 Hoffmann-La Roche Ltd. Retinal Disorders Treatment Major Product Offerings
  7.3.4 Hoffmann-La Roche Ltd. Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.3.5 Hoffmann-La Roche Ltd. Key News
7.4 Graybug Vision, Inc.
  7.4.1 Graybug Vision, Inc. Corporate Summary
  7.4.2 Graybug Vision, Inc. Business Overview
  7.4.3 Graybug Vision, Inc. Retinal Disorders Treatment Major Product Offerings
  7.4.4 Graybug Vision, Inc. Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.4.5 Graybug Vision, Inc. Key News
7.5 Kubota Pharmaceutical Holdings Co., Ltd.
  7.5.1 Kubota Pharmaceutical Holdings Co., Ltd. Corporate Summary
  7.5.2 Kubota Pharmaceutical Holdings Co., Ltd. Business Overview
  7.5.3 Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Major Product Offerings
  7.5.4 Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.5.5 Kubota Pharmaceutical Holdings Co., Ltd. Key News
7.6 Novartis AG
  7.6.1 Novartis AG Corporate Summary
  7.6.2 Novartis AG Business Overview
  7.6.3 Novartis AG Retinal Disorders Treatment Major Product Offerings
  7.6.4 Novartis AG Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.6.5 Novartis AG Key News
7.7 Regeneron Pharmaceuticals, Inc.
  7.7.1 Regeneron Pharmaceuticals, Inc. Corporate Summary
  7.7.2 Regeneron Pharmaceuticals, Inc. Business Overview
  7.7.3 Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Major Product Offerings
  7.7.4 Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.7.5 Regeneron Pharmaceuticals, Inc. Key News
7.8 Santen Pharmaceutical Co., Ltd.
  7.8.1 Santen Pharmaceutical Co., Ltd. Corporate Summary
  7.8.2 Santen Pharmaceutical Co., Ltd. Business Overview
  7.8.3 Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Major Product Offerings
  7.8.4 Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.8.5 Santen Pharmaceutical Co., Ltd. Key News
7.9 Takeda Pharmaceutical Company Limited
  7.9.1 Takeda Pharmaceutical Company Limited Corporate Summary
  7.9.2 Takeda Pharmaceutical Company Limited Business Overview
  7.9.3 Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Major Product Offerings
  7.9.4 Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.9.5 Takeda Pharmaceutical Company Limited Key News
7.10 Pfizer
  7.10.1 Pfizer Corporate Summary
  7.10.2 Pfizer Business Overview
  7.10.3 Pfizer Retinal Disorders Treatment Major Product Offerings
  7.10.4 Pfizer Retinal Disorders Treatment Revenue in Global Market (2017-2022)
  7.10.5 Pfizer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Retinal Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Retinal Disorders Treatment Market Drivers in Global Market
Table 3. Retinal Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Retinal Disorders Treatment in Global Market
Table 5. Top Retinal Disorders Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Retinal Disorders Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Retinal Disorders Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Retinal Disorders Treatment Product Type
Table 9. List of Global Tier 1 Retinal Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Retinal Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Retinal Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Retinal Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Retinal Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Retinal Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Retinal Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Retinal Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Retinal Disorders Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Retinal Disorders Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Retinal Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Retinal Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Retinal Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Retinal Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Retinal Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Allergan plc Corporate Summary
Table 31. Allergan plc Retinal Disorders Treatment Product Offerings
Table 32. Allergan plc Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bayer AG, F. Corporate Summary
Table 34. Bayer AG, F. Retinal Disorders Treatment Product Offerings
Table 35. Bayer AG, F. Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Hoffmann-La Roche Ltd. Corporate Summary
Table 37. Hoffmann-La Roche Ltd. Retinal Disorders Treatment Product Offerings
Table 38. Hoffmann-La Roche Ltd. Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Graybug Vision, Inc. Corporate Summary
Table 40. Graybug Vision, Inc. Retinal Disorders Treatment Product Offerings
Table 41. Graybug Vision, Inc. Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Kubota Pharmaceutical Holdings Co., Ltd. Corporate Summary
Table 43. Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Product Offerings
Table 44. Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis AG Corporate Summary
Table 46. Novartis AG Retinal Disorders Treatment Product Offerings
Table 47. Novartis AG Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Regeneron Pharmaceuticals, Inc. Corporate Summary
Table 49. Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Product Offerings
Table 50. Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Santen Pharmaceutical Co., Ltd. Corporate Summary
Table 52. Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Product Offerings
Table 53. Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Takeda Pharmaceutical Company Limited Corporate Summary
Table 55. Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Product Offerings
Table 56. Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Retinal Disorders Treatment Product Offerings
Table 59. Pfizer Retinal Disorders Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Retinal Disorders Treatment Segment by Type in 2021
Figure 2. Retinal Disorders Treatment Segment by Application in 2021
Figure 3. Global Retinal Disorders Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Retinal Disorders Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Retinal Disorders Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Retinal Disorders Treatment Revenue in 2021
Figure 8. By Type - Global Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 12. US Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 24. China Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Retinal Disorders Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Retinal Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan plc Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer AG, F. Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hoffmann-La Roche Ltd. Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Graybug Vision, Inc. Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kubota Pharmaceutical Holdings Co., Ltd. Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis AG Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Regeneron Pharmaceuticals, Inc. Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Santen Pharmaceutical Co., Ltd. Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda Pharmaceutical Company Limited Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Retinal Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)